In this Issue
Chief Medical Editor’s Page
By Steven D. Vold, MD
By Melissa (Wen-Jeng) Yao, MD, and Jeffrey S. Schultz, MD
By Christopher A. Girkin, MD
Practical research may lead to the better care of patients with glaucoma.
By Albert S. Khouri, MD, and Tony Realini, MD, MPH
By Jess T. Whitson, MD
By Anurag Shrivastava, MD
Technology can help us to communicate with primary health providers to coordinate care.
By George Shafranov, MD
The Principles of Glaucoma Management
These steps are imperative to accurate diagnosis and treatment.
By Yara P. Catoira-Boyle, MD
This technology enhances physicians’ ability to diagnose disease and its progression, but clinical acumen is still essential.
By Ian Conner, MD, PhD, and Joel S. Schuman, MD
Recently released preservative-free agents will create a new paradigm for the treatment of glaucoma.
By Lawrence M. Hurvitz, MD
The answer is highly variable and influenced by commercial considerations, the patient, and the physician.
By Nicholas P. Bell, MD
Optimizing patients’ outcomes.
By Henry D. Jampel, MD, MHS
This proven and effective treatment modality is a powerful option for initial IOP lowering in the newly diagnosed glaucomatous or ocular hypertensive patient.
By Ahmad A. Aref, MD
The procedure is still viable.
By Richard A. Lehrer, MD
Technical pearls and advice on selecting a device for tube shunt surgery.
By Boris Dilman, MD, and Anjali S. Hawkins, MD, PhD
Stratifying the disease may improve communication between physicians and their patients and educate payors.
By Ronald L. Fellman, MD
By Nathan M. Radcliffe, MD
Dr. Singh predicts how microinvasive glaucoma surgery will affect ophthalmologists’ treatment of the disease and describes one of his star-studded evenings.